ARA-290
An erythropoietin-derived peptide studied for innate-repair-receptor signaling.
Research Overview
ARA-290 (cibinetide) is an 11-amino-acid peptide derived from the helix-B region of erythropoietin. It is studied as a selective agonist of the innate repair receptor — a heterocomplex of the EPO receptor and the β-common receptor (CD131) — associated with tissue protection and anti-inflammatory signaling.
Importantly, it is non-erythropoietic, separating tissue-protective signaling from red-blood-cell effects, which makes it a focused research tool.
Specifications
| Compound | ARA-290 (Cibinetide) |
| Classification | Regenerative research compound |
| Molecular weight | 1,258.42 g/mol |
| Sequence / Form | 11-aa EPO helix-B fragment |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
